On the one hand, butyrate can inhibit pro-inflammatory mediators TNF-α, IL-1β, IL-6, and IL-8, and up-regulate anti-inflammatory factor IL-10; on the other hand, butyrate can promote anti-tumor immunity by promoting CD8+T cells to play a role. Here, CD8A is linked to neoplasm.